Old Web
English
Sign In
Acemap
>
Paper
>
Catumaxomab (Removab) – Trifunctional Antibodies: Combining Direct Tumor Cell Killing with Therapeutic Vaccination
Catumaxomab (Removab) – Trifunctional Antibodies: Combining Direct Tumor Cell Killing with Therapeutic Vaccination
2014
Horst Lindhofer
Michael Stanglmaier
Raymund Buhmann
Michael Jäger
Daniel Klunker
Peter Ruf
Juergen Hess
Keywords:
Antibody
Catumaxomab
Vaccination
Cell
Immunology
Virology
Medicine
tumor cells
cancer therapy
Correction
Source
Cite
Save
Machine Reading By IdeaReader
108
References
0
Citations
NaN
KQI
[]